EIGR

Why Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?

By William White, InvestorPlace Writer
Eiger BioPharmaceuticals (EIGR) stock is falling on Wednesday after the biopharmaceutical company halted a Phase 3 clinical trial.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer
It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!